NEXGEL, INC. Restricted Cash, Current
NEXGEL, INC. (NXGL) had Restricted Cash, Current of $1.21 million as of 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Restricted Cash and Cash Equivalent, Current
us-gaap:RestrictedCashCurrent · last filed 2026-08-17
- 2026-06-30: Restricted Cash, Current $1.21M.
- 2026-03-31: Restricted Cash, Current $1.91M.
- 2025-12-31: Restricted Cash, Current $741.00K.
- 2025-09-30: Restricted Cash, Current $920.00K.
| Period end | Restricted Cash, Current |
|---|---|
| 2026-06-30 | $1.21M 10-Q · filed 2026-08-17 |
| 2026-03-31 | $1.91M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $741.00K 10-Q · filed 2026-05-14 |
| 2025-09-30 | $920.00K 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |